Abbott Laboratories (Pakistan) (KAR:ABOT) 3-Year EBITDA Growth Rate : -17.40% (As of Mar. 2024)

View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) 3-Year EBITDA Growth Rate?

Abbott Laboratories (Pakistan)'s EBITDA per Share for the three months ended in Mar. 2024 was ₨23.45.

During the past 12 months, Abbott Laboratories (Pakistan)'s average EBITDA Per Share Growth Rate was -0.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -17.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Abbott Laboratories (Pakistan) was 29.00% per year. The lowest was -17.40% per year. And the median was 14.50% per year.

Competitive Comparison of Abbott Laboratories (Pakistan)'s 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories (Pakistan)'s 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s 3-Year EBITDA Growth Rate falls into.

Abbott Laboratories (Pakistan) 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Abbott Laboratories (Pakistan) (KAR:ABOT) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Abbott Laboratories (Pakistan) 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120

Website

https://www.pk.abbott

Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines